Stamford, CT -- (SBWIRE) -- 01/10/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Receptos Inc (NASDAQ:RCPT), InterMune Inc (NASDAQ:ITMN), Angie's List Inc (NASDAQ:ANGI), Capstone Turbine Corporation (NASDAQ:CPST)
Receptos Inc (NASDAQ:RCPT) opened the session at $32.34, trading in a range of $32.00 - $36.15. The stock showed a positive performance of +2.59% in the last trading session from its previous close of $31.53 and closed at $35.50. The stock traded on a volume of 2.60 million shares and the average volume of the stock remained 162,092 shares. Receptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company’s product candidates span three specialty disease areas. The Company’s lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD).
For How Long RCPT will Fight for Profitability? Read This Trend Analysis report
InterMune Inc (NASDAQ:ITMN) traded 2.33 million shares in the last business day while the average volume of the stock remained 853,978 shares. The stock showed a positive movement of +9.52% to end at $16.57. The 52 week range of the stock remained $8.21 - $16.88. InterMune, Inc. (InterMune), is a biotechnology company focused on the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases. Pulmonology is the field of medicine concerned with the diagnosis and treatment of lung conditions. The Company has a product in pulmonology, pirfenidone, which is an orally active, small molecule compound. On January 2, 2013, the Company began the commercial launch of Esbriet in Canada. June 19, 2012, the Company completed the divestiture of its worldwide development and commercialization rights to the pharmaceutical product containing Interferon Gamma-1b sold by the Company under the tradename Actimmune.
For How Long ITMN’s Gloss will Attract Investors? Find out via this report
Angie's List Inc (NASDAQ:ANGI) reported 3.28 million shares were exchanged during the last trade, while the average volume is about 1.00 million shares. The stock escalated +8.39% and finished the day at $14.85. Angie’s List, Inc. (Angie’s List) operates a consumer-driven service for members to research, hire, rate and review local professionals for critical needs, such as home, health care and automotive services. As of December 31, 2012, the Company offered its service to approximately 1.7 million paying members in 219 local markets in the United States. The Company helps consumers purchase high cost of failure services in an extremely fragmented local marketplace.
For How Long ANGI’s Gloss will Attract Investors? Find out via this report
Capstone Turbine Corporation (NASDAQ:CPST) shares rose, +8.28 percent from its previous close of $1.45 to close at $1.57. Traded with volume of 20.25 million shares in the prior session and the average volume of the stock remained 2.92 million shares. Capstone Turbine Corporation (Capstone) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications, including cogeneration (combined heat and power (CHP), integrated combined heat and power (ICHP), and combined cooling, heat and power (CCHP)), renewable energy, natural resources and critical power supply.
Why Should Investors Buy CPST After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)